Inductive Bio has demonstrated value across dozens of active drug programs, significantly increasing revenue last year.
Founders
Josh Haimson, Ben Birnbaum
Company Description
Inductive Bio has developed a collaborative AI platform that dramatically accelerates compound optimization, a critical and time-consuming step in developing new therapeutics. The platform combines purpose-built machine learning models with intuitive design software to help scientists efficiently navigate chemical space and design higher-quality drug candidates.